Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Colorcon
Fuji
Harvard Business School
QuintilesIMS
Cantor Fitzgerald
Citi
Covington
US Army

Generated: December 9, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,124,363

« Back to Dashboard

Which drugs does patent 6,124,363 protect, and when does it expire?

Patent 6,124,363 protects TIKOSYN and is included in one NDA.

This patent has fifty-four patent family members in forty-six countries.

Summary for Patent: 6,124,363
Title: Dofetilide polymorphs
Abstract:The invention relates to the substantially pure dofetilide polymorphs P162, P162a and P143, and to processes for the preparation of, compositions containing and to the uses of, such polymorphs.
Inventor(s): Appleby; Ian Colin (Sandwich, GB), Newbury; Trevor Jack (Sandwich, GB), Nichols; Gary (Sandwich, GB)
Assignee: Pfizer Inc. (New York, NY)
Application Number:09/423,986
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,124,363
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Dosage form; Use;

Drugs Protected by US Patent 6,124,363

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Pfizer TIKOSYN dofetilide CAPSULE;ORAL 020931-001 Oct 1, 1999 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer TIKOSYN dofetilide CAPSULE;ORAL 020931-002 Oct 1, 1999 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer TIKOSYN dofetilide CAPSULE;ORAL 020931-003 Oct 1, 1999 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,124,363

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9722662Oct 27, 1997
PCT Information
PCT FiledOctober 09, 1998PCT Application Number:PCT/EP98/06641
PCT Publication Date:May 06, 1999PCT Publication Number: WO99/21829

International Family Members for US Patent 6,124,363

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 906 ➤ Try a Free Trial
Argentina 015193 ➤ Try a Free Trial
Austria 232199 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Citi
McKinsey
Moodys
Boehringer Ingelheim
Cantor Fitzgerald
US Department of Justice
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.